NCT02992171 Primary Palliative Care for Patients With Advanced Hematologic Malignancies Status COMPLETED Phase NA
NCT02980289 DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. Status COMPLETED Phase N/A
NCT02957565 Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit Status COMPLETED Phase NA
NCT02944864 A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics Status TERMINATED Phase PHASE1
NCT02930876 Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients Status COMPLETED Phase PHASE2
NCT02919696 A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers Status COMPLETED Phase PHASE1
NCT02915172 Lenvatinib and Capecitabine in Patients With Advanced Malignancies Status WITHDRAWN Phase PHASE1
NCT02889445 A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers Status NO_LONGER_AVAILABLE Phase N/A
NCT02860780 A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT02857270 A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer Status COMPLETED Phase PHASE1
NCT02841124 Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies. Status COMPLETED Phase NA
NCT02825563 A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients Status COMPLETED Phase PHASE1
NCT02805660 Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC Status TERMINATED Phase PHASE1/PHASE2
NCT02801097 RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) Status TERMINATED Phase PHASE1
NCT02797795 A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT02778126 A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer Status COMPLETED Phase PHASE1